直径1~4 cm的分化型甲状腺癌的诊治进展

doi:10.3877/cma.j.issn.1674-0785.2021.02.013

随着影像技术和病理诊断的发展，分化型甲状腺癌（DTC）的早诊率逐渐增高，但肿瘤直径为1~4 cm的患者仍占所有DTC的30%左右。近年来诊疗指南的更新对DTC诊疗方案影响很大，特别是肿瘤直径为1~4 cm的患者。应根据初始风险评估来制定科学合理的手术方案，并在随访中动态地进行风险评估及时调整患者随访策略，以期达到精准、实时的个体化管理，让越来越多患者在治疗中获益。

关键词: 分化型甲状腺癌, 肿瘤直径, 临床决策

With the development of imaging technology and pathological diagnosis, the rate of early diagnosis of differentiated thyroid cancer (DTC) has gradually increased. However, patients with a tumor diameter of 1 to 4 cm still account for about 30% of all DTC cases. In recent years, the update of diagnosis and treatment guidelines has a great impact on the treatment scheme of DTC, especially for patients with a tumor diameter of 1-4 cm. A scientific and reasonable surgical plan should be developed according to the initial risk assessment, the risk assessment should be carried out dynamically in the follow-up, and the follow-up strategy for patients should be adjusted in time, in order to achieve accurate and real-time individualized management, so that more and more patients can benefit from the treatment.

Key words: Differentiated thyroid cancer, Tumor diameter, Clinical decision

1	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
2	中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版) [J/OL]. 中华普通外科学文献(电子版), 2019, 13(1): 1-15.
3	Haugen BR, Alexander EK, Bible KC. The American Thyroid Association (ATA) guidelines task force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016, 26: 1-133.
4	Doescher J, Veit JA, Hoffmann TK. The 8th edition of the AJCC Cancer Staging Manual [J]. HNO, 2017, 65(12): 956-961.
5	郑向前, 候秀坤, 高明. 2017年第二版NCCN甲状腺肿瘤指南解读 [J]. 中国肿瘤临床, 2018, 45(1): 14-17.
6	Filetti S, Durante C, Hartl DM, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2019, 30(12): 1856-1883.
7	Yang F, Zhong Q, Huang Z, et al. Survival in papillary thyroid microcarcinoma: a comparative analysis between the 7th and 8th Versions of the AJCC/UICC staging system based on the SEER database [J]. Front Endocrinol, 2019, 10: 1-10.
8	Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival an analysis of 61,775 patients [J]. Ann Surg, 2014, 260(4): 601-607.
9	Liu J, Zhang Z, Huang H, et al. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis [J]. Oral Oncol, 2019, 90: 17-22.
10	Ullmann TM, Gray KD, Stefanova D, et al. The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer [J]. Surgery, 2019, 166(3): 349-355.
11	Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer [J]. Ann Surg, 2007, 246(3): 375-381.
12	Randolph GW, Shin JJ, Grillo HC, et al. The surgical management of goiter: Part II. Surgical treatment and results [J]. The Laryngoscope, 2011, 121(1): 68-76.
13	Hauch A, Al-Qurayshi Z, Randolph G, et al. Total Thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons [J]. Ann Surg Oncol, 2014, 21(12): 3844-3852.
14	Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension [J]. Thyroid, 2012, 22(11): 1144-1152.
15	黄樱城, 李正江. 分化型甲状腺癌治疗管理和动态风险评估现状 [J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(5): 389-393.
16	O'Connell K, Yen TW, Quiroz F, et al. The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer [J]. Surgery, 2013, 154(4): 697-703.
17	管小青, 李辉, 沈毅, 等. cN0分化型甲状腺癌颈部中央区淋巴结术中快速病理对颈侧区淋巴结清扫的指导意义 [J]. 中国肿瘤外科杂志, 2020, 12(5): 412-416.
18	Nixon IJ, Shaha AR, Patel SG. Surgical diagnosis: frozen section and the extent of surgery [J]. Otolaryngol Clin North Am, 2014, 47(4): 519-528.
19	Jin BJ, Kim MK, Ji YB, et al. Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma [J]. Oral Oncology, 2015, 51(8): 759-763.
20	黄璐, 李超, 王薇, 等. 甲状腺癌腺外侵犯的意义及最新研究进展 [J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(9): 717-720.
21	Nixon IJ, Ganly I, Patel S, et al. The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer [J]. Surgery, 2011, 150(6): 1242-1249.
22	Youngwirth L, Adam MA, Scheri RP, et al. Extrathyroidal extension is associated with compromised survival in patients with thyroid cancer [J]. Thyroid, 2017, 27(5): 626-631.
23	Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002 [J]. JAMA, 2006, 295(18): 2164.
24	Ito Y, Kudo T, Kihara M, et al. Prognosis of low-risk papillary thyroid carcinoma patients: Its relationship with the size of primary tumors [J]. Endocr J, 2012, 59(2): 119-125.
25	宋娟娟, 刘延晴, 林岩松. 中低危分化型甲状腺癌低剂量131I治疗后短期转归的临床分析 [J]. 中国癌症杂志, 2019, 29(3): 207-211.
26	Albano D, Bonacina M, Durmo R, et al. Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer [J]. Endocrine, 2020, 68(1): 1-8.
27	于振坤, 张海东, 何双八. 分化型甲状腺癌手术: 全切vs腺叶切除——医生、患者与肿瘤三因素的平衡与思考 [J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(24): 1909-1910, 1917.
28	Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging [J]. Endocrinol Metab Clin North Am, 2014, 43(2): 401-421.
29	Shen X, Zhu G, Liu R, et al. Patient age–associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer [J]. J Clin Oncol, 2017, 36(5): 438-445.
30	Liu X, Qu S, Liu R, et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer [J]. J Clin Endocrinol Metab, 2014, 99(6): 1130-1136.
31	Sun R, Li C, Zhou Y, et al. Predictive role of intraoperative clinicopathological features of the central compartment in estimating lymph nodes metastasis status [J]. Ann Transl Med, 2019, 7(18): 471.

[1]	张峰, 谢良骏, 陈宇导, 程木华. 分化型甲状腺癌术后肺转移的SPECT/CT平面与断层显像诊断研究[J]. 中华普通外科学文献(电子版), 2017, 11(05): 340-343.
[2]	李龙山, 孙鹏飞. 分化型甲状腺癌治疗的现状和进展[J]. 中华普通外科学文献(电子版), 2017, 11(03): 208-212.
[3]	王培顺, 黎洪浩, 黄天立, 龙淼云, 罗定远, 黄明清, 彭新治. 血清促甲状腺激素水平与分化型甲状腺癌致病风险关系研究[J]. 中华普通外科学文献(电子版), 2011, 05(06): 512-515.
[4]	周宏, 姚陈, 赖远辉, 罗光辉, 陈永年. 分化型甲状腺癌外科手术方式探讨[J]. 中华普通外科学文献(电子版), 2010, 04(03): 246-251.
[5]	杨河, 符敏, 王琳, 胡军, 梁振雄. 解剖性肝切除术对肿瘤直径≤2 cm合并微血管瘤栓（MVI）的肝细胞癌患者临床疗效及预后影响研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 605-609.
[6]	湛海伦, 陈雪莲, 杨飞, 李文标, 李腾成, 蔡佳荣, 毛云华, 罗云, 周祥福. 无管化经皮肾镜的病例选择和术中决策[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(03): 204-207.
[7]	刘宇鹏, 杨荣利, 万献尧. 重型新型冠状病毒肺炎的临床决策与思考[J]. 中华重症医学电子杂志, 2020, 06(03): 329-334.
[8]	张馨文, 唐永, 汪雯. 临床决策支持系统在基层抗菌药物合理使用中的作用[J]. 中华临床医师杂志(电子版), 2019, 13(07): 532-536.
[9]	吴东. 临床决策原理及其能力培养[J]. 中华诊断学电子杂志, 2015, 03(04): 235-239.
[10]	杨志寅. 临床思维与临床决策[J]. 中华诊断学电子杂志, 2015, 03(02): 79-83.
[11]	王佳凤, 郭锐, 陈倩倩, 李惠凯, 宁波, 袁新普, 朱华, 令狐恩强. ⁶⁸Ga-NC-BCH联合PET-CT淋巴结免疫示踪对于胃癌患者术前及术后临床决策影响的初步探索研究[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 253-257.
[12]	刘俊宏, 施贵冬, 付茂勇, 周瑜, 刘艳, 李东林, 宁东. 食管癌术后食管胃吻合口狭窄的危险因素及对策[J]. 中华胸部外科电子杂志, 2018, 05(03): 159-163.
[13]	朱晓磊, 朱自江, 庞瑶, 王文昊, 脱广鑫. 胸腺瘤的外科治疗和预后分析[J]. 中华胸部外科电子杂志, 2018, 05(02): 107-112.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Progress in diagnosis and treatment of differentiated thyroid carcinoma with a tumor diameter of 1 to 4 cm

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Progress in diagnosis and treatment of differentiated thyroid carcinoma with a tumor diameter of 1 to 4 cm